Literature DB >> 1520589

Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up.

I de Mascarel1, F Bonichon, J M Coindre, M Trojani.   

Abstract

Special techniques such as serial macroscopic sectioning (SMS) or immunohistochemical staining (IH) improve the detection rate of micrometastases but this detection is of value only if it improves the prediction of recurrence and survival. We first studied the prognosis of 120 patients with a single micrometastasis detected by SMS in a series of 1,680 primary operable breast carcinoma with a median follow-up of 7 years. A significant difference in recurrence (P = 0.005) and in survival (P = 0.0369) was found between node-negative patients and those with one single SMS micrometastasis, but SMS micrometastases were not a predicting factor by multivariate analyses according to the Cox model. We then studied the prognostic significance of patients with a micrometastasis detected by IH in node-negative carcinoma: 37 micrometastases from a series of 89 invasive lobular carcinoma (ILC) and 13 single micrometastases from a series of 129 invasive ductal carcinoma (IDC). In the ILC group, IH micrometastases had no prognostic value (median follow-up: 9.3 years). In the IDC group, IH micrometastases were correlated with recurrences (P = 0.01) and were the most significant predicting factor, but were less correlated with survival (median follow-up: 15.6 years). Three main points emerge from this study: (1) SMS micrometastases have a prognostic significance and macroscopic sectioning is recommended as a routine technique not requiring excessive work. (2) IH micrometastases in infiltrating lobular carcinoma have no prognostic significance. (3) The value of IH is debatable in infiltrating ductal carcinoma, since the technique is of principal use in predicting recurrences. It should therefore be carefully assessed vs other prognostic factors currently under study.

Entities:  

Mesh:

Year:  1992        PMID: 1520589      PMCID: PMC1977929          DOI: 10.1038/bjc.1992.306

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

Review 1.  Are breast cancer axillary node micrometastases worth detecting?

Authors:  A M Neville
Journal:  J Pathol       Date:  1990-08       Impact factor: 7.996

2.  Detection and significance of occult axillary node metastases in patients with invasive breast cancer.

Authors:  E R Fisher; S Swamidoss; C H Lee; H Rockette; C Redmond; B Fisher
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

Review 3.  How to use prognostic factors in axillary node-negative breast cancer patients.

Authors:  W L McGuire; A K Tandon; D C Allred; G C Chamness; G M Clark
Journal:  J Natl Cancer Inst       Date:  1990-06-20       Impact factor: 13.506

4.  [Detection of micrometastases in excised regional lymph nodes in cancer of the breast. Systematic use of KL1 anticytokeratin monoclonal antibodies in a prospective series of 120 T2 N- patients].

Authors:  P Noel; E Tabone; J P Michot; M Groleas; M Hesch; A M Rifki
Journal:  Ann Pathol       Date:  1989       Impact factor: 0.407

5.  The use of monoclonal antibodies for the histopathological detection of mammary axillary micrometastases.

Authors:  J Byrne; R Waldron; D McAvinchey; P Dervan
Journal:  Eur J Surg Oncol       Date:  1987-10       Impact factor: 4.424

6.  Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma.

Authors:  S Friedman; F Bertin; H Mouriesse; A Benchabat; J Genin; D Sarrazin; G Contesso
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

7.  Prognostic significance of cytokeratin-positive breast cancer metastases.

Authors:  D D Sedmak; T A Meineke; D S Knechtges; J Anderson
Journal:  Mod Pathol       Date:  1989-09       Impact factor: 7.842

8.  Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.

Authors:  P P Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

9.  Immunohistochemical investigation of axillary lymph nodes for micrometastases in patients with breast cancer using E29.

Authors:  A Cavaliere; B Falini; G Antonini
Journal:  Tumori       Date:  1989-12-31

10.  Micrometastases to axillary lymph nodes from invasive lobular carcinoma of breast: detection by immunohistochemistry and prognostic significance.

Authors:  M Trojani; I de Mascarel; J M Coindre; F Bonichon
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more
  34 in total

1.  Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases.

Authors:  Holm Eggemann; Atanas Ignatov; Madeleine Hetterich; Michael Gerken; Olaf Ortmann; Elisabeth C Inwald; Monika Klinkhammer-Schalke
Journal:  Breast Cancer Res Treat       Date:  2021-03-15       Impact factor: 4.872

2.  Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.

Authors:  Dean Bogoevski; Emre F Yekebas; Paulus Schurr; Jussuf T Kaifi; Asad Kutup; Andreas Erbersdobler; Klaus Pantel; Jakob R Izbicki
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

3.  A rapid, fully automated, molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer.

Authors:  Steven J Hughes; Liqiang Xi; Siva Raja; William Gooding; David J Cole; William E Gillanders; Keidi Mikhitarian; Kenneth McCarty; Susan Silver; Jesus Ching; William McMillan; James D Luketich; Tony E Godfrey
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

4.  Micrometastasis Detection using Special Stains in Nodal Tissues of Oral Squamous Cell Carcinoma - A Histochemical Study.

Authors:  Wasim Raja Mumtaz; Veda Hegde; Nikhil Yadav
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  Statistical kinematics of axillary nodal metastases in breast carcinoma.

Authors:  Wayne S Kendal
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

6.  Predictors for nonsentinel node involvement in breast cancer patients with micrometastases in the sentinel lymph node.

Authors:  Archana Ganaraj; Joseph A Kuhn; Ronald C Jones; Michael D Grant; Valerie R Andrews; Sally M Knox; Georges J Netto; Basel Altrabulsi; Sheryl A Livingston; Todd M McCarty
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

7.  Prognostic factors in primary breast carcinoma.

Authors:  S E Pinder; I O Ellis; C W Elston
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

8.  Strong prognostic value of nodal and bone marrow micro-involvement in patients with pancreatic ductal carcinoma receiving no adjuvant chemotherapy.

Authors:  Emre-F Yekebas; Dean Bogoevski; Michael Bubenheim; Björn-Christian Link; Jussuf-T Kaifi; Robin Wachowiak; Oliver Mann; Asad Kutup; Guellue Cataldegirmen; Lars Wolfram; Andreas Erbersdobler; Christoph Klein; Klaus Pantel; Jakob-R Izbicki
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 9.  Pancreatic cancer: a generalized disease--prognostic impact of cancer cell dissemination.

Authors:  D Bogoevski; T Strate; E F Yekebas; J R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

Review 10.  Ultrastaging of lymph node in uterine cancers.

Authors:  Corinne Bézu; Charles Coutant; Marcos Ballester; Jean-Guillaume Feron; Roman Rouzier; Serge Uzan; Emile Daraï
Journal:  J Exp Clin Cancer Res       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.